BioCorRx, Inc. Announces Distribution Rights in Ohio for Start Fresh Program
01 Julho 2014 - 9:00AM
BioCorRx, Inc. (OTCQB: BICX), a leader in addiction treatment
and rehabilitation programs, announced it has closed another sale
for the exclusive license and distribution rights of its Start
Fresh Program to Sobriety and Addictions Solutions, LLC.
Under the terms of the agreement, Sobriety and Addictions Solutions
has paid BioCorRx, Inc. an upfront licensing fee and will also pay
an upfront fee per program ordered in the state of Ohio. The
closing of the Ohio territory marks the third transaction between
Sobriety and Addictions Solutions, LLC and BioCorRx, Inc. The
previous two transactions included the combined areas of Northern
California, North Carolina, Maryland, Virginia, West Virginia, and
Washington D.C.
The population of Ohio is just over 11.5 million people and the
state is uniquely situated in that it is within only one day's
drive of 50% of all of North America's population. Bringing
the Start Fresh Program to Ohio gives hope not only to residents of
the state, but to those within driving distance as well. Ohio
recently saw a 24% increase in drunk driving deaths according to
MADD and binge drinking rates in the state have been on a steady
incline over the last decade. A new study just released by the
Centers for Disease Control found that excessive drinking, both
regular heavy drinking and occasional binge drinking, cause 1 in 10
deaths of working age adults. According to the study's
findings alcohol abuse is now the third largest preventable cause
of death in this age group, which cut an average of 30 years off
the lives of those who died. Ohio has also been a victim of
the opiate epidemic that has been grabbing national attention in
recent years. One county saw the number of heroin deaths
increase four fold in just a four-year period.
"We are very pleased with this latest license deal as it will
broaden access to the Start Fresh Program in yet another state with
dismal drug and alcohol abuse statistics. This group is
helping patients regularly in their two Northern California
locations found in the San Francisco metro area and Fresno.
They are also working diligently at getting their Washington D.C.
clinic open soon. We are pleased that the success they are
seeing in their clinics is pushing them to expand quickly," said
Kent Emry, CEO of BioCorRx, Inc. "Broadening our reach
further throughout the Midwest is yet another step towards our goal
of making the Start Fresh Program available to everyone, regardless
of their location."
Media
Click here to view Recent National Television Media on
the BioCorRx YouTube Channel
Click here for company Facebook page for more stories
and media coverage
About BioCorRx, Inc.
BioCorRx, Inc. (OTCQB: BICX) is an addiction
treatment and rehabilitation company on the leading edge of
addiction treatment. The company has developed a highly effective
program called the Start Fresh ProgramTM consisting of two
components used by various addiction clinics in the US. Clinic
reports show that the treatment program has an extremely high
success rate with individuals that complete the program. The first
component of the program consists of an outpatient implant
procedure performed by a licensed physician that delivers
therapeutic levels of the drug Naltrexone, an opioid antagonist
that significantly reduces physical cravings for alcohol and
opioids, into the body. The second component of the program
developed by BioCorRx, Inc. is a one on one coaching program
specifically tailored for the treatment of alcoholism and other
substance abuse addictions. For more information on BICX, visit
www.BioCorRx.com.
Safe Harbor Statement
The information in this release includes
forward-looking statements. These forward-looking statements
generally are identified by the words "believe," "project,"
"estimate," "become," "plan," "will," and similar expressions.
These forward-looking statements involve known and unknown risks as
well as uncertainties, including those discussed in the following
cautionary statements and elsewhere in this release. Although the
Company believes that its expectations are based on reasonable
assumptions, the actual results that the Company may achieve may
differ materially from any forward-looking statements, which
reflect the opinions of the management of the Company only as of
the date hereof.
CONTACT: Investor Relations
SmallCapVoice.com, Inc.
512-267-2430
BioCorRx (QB) (USOTC:BICX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
BioCorRx (QB) (USOTC:BICX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024